| # | Drug | Count |
|---|---|---|
| 0 | PERTUZUMAB | 9 |
| 1 | TRASTUZUMAB | 9 |
| 2 | PROPOFOL | 8 |
| 3 | SEVOFLURANE | 6 |
| 4 | CYCLOPHOSPHAMIDE | 5 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 7 | DOXORUBICIN | 5 |
| 8 | SUGAMMADEX | 5 |
| 9 | ADRENALINUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUGAMMADEX SODIUM | 3 | 0.0023 |
| 1 | SUGAMMADEX | 5 | 0.0018 |
| 2 | ANDEXANET ALFA | 1 | 0.0014 |
| 3 | REMIFENTANIL HYDROCHLORIDE | 2 | 0.0008 |
| 4 | SEVOFLURANE | 6 | 0.0007 |
| 5 | CISATRACURIUM BESYLATE | 1 | 0.0004 |
| 6 | PERFLUOROHEXYLOCTANE | 1 | 0.0004 |
| 7 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| 8 | ROCURONIUM BROMIDE | 4 | 0.0003 |
| 9 | PERTUZUMAB | 9 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 9 |
| 1 | Corticosteroid [EPC] | 8 |
| 2 | General Anesthetic [EPC] | 8 |
| 3 | Catecholamine [EPC] | 6 |
| 4 | Alkylating Drug [EPC] | 5 |
| 5 | alpha-Adrenergic Agonist [EPC] | 4 |
| 6 | beta-Adrenergic Agonist [EPC] | 4 |
| 7 | Loop Diuretic [EPC] | 3 |
| 8 | Microtubule Inhibitor [EPC] | 3 |
| 9 | Opioid Agonist [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 1 | General Anesthetic [EPC] | 8 | 0.0002 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 9 | 0.0001 |
| 3 | Catecholamine [EPC] | 6 | 0.0001 |
| 4 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 8 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |